Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 28, 2008

View Archived Issues

Recent patents describe new therapeutic agents for asthma and other respiratory disorders

New compounds for neurological disorders reported in recent patents

Recent patent literature discloses novel therapeutic agents for metabolic disorders

RN-18 inhibits viral replication by targeting a novel HIV-1 protein

Interim results from a first-in-human study with GSK-461364 in advanced solid tumor patients

Vidaza receives positive opinion from CHMP for treatment of MDS and AML

FDA accepts as complete for review Meda's NDA for azelastine antihistamine nasal spray

Biotie Therapies to acquire Elbion GmbH

Avid receives positive feedback from FDA regarding amyloid imaging compound AV-45

Schering-Plough's asenapine meets primary endpoint in schizophrenia relapse prevention trial

Noscira to initiate phase II NP-12 study in Alzheimer's disease

FDA approves LoSeasonique oral contraceptive

Ofatumumab demonstrates sustained efficacy in phase I/II rheumatoid arthritis trial

Early bactericidal activity seen with PA-824 in phase IIa tuberculosis study

Prokinetic effects of PF-00885706 evaluated in healthy volunteers

ALV-003 alters effects of gluten in celiac disease patients

Kowa submits NDA to FDA for pitavastatin

Merck Serono submits sNDA for Gonal-f in Japan for ovulation induction

Erbitux receives CHMP positive opinion for first-line use in head and neck cancer

Novartis launches Simulect in Japan for transplantation

Compugen launches viral peptides discovery platform for immune and inflammatory diseases

Omrix to resume enrollment in phase II clinical trial of Fibrin Pad

Stallergenes launches phase III Oralair Grasses trial in the U.S.

Kamada reports results from pivotal phase III trial of alpha-1 antitrypsin

Epigenomics presents update on PRESEPT clinical study of Septin 9 biomarker in colorectal cancer

Novel analgesics described in a recent University of Tennessee patent

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 5, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
MicroRNAs in circulating extracellular vesicles as IPF biomarkers
BioWorld Science
MicroRNAs (miRNAs) are small noncoding RNAs gaining increasing attention due to their crucial role in gene expression regulation and influence in various cellular...
MJFF grant supports Bexorg’s translational biomarker work
BioWorld Science
Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...
REST emerges as biomarker in ALS, knockdown improves ALS symptoms
BioWorld Science
About 10% of amyotrophic lateral sclerosis (ALS) cases result from inherited genetic mutations, with about 20% of them attributed to mutations in the gene...